Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Nov 14;369(20):1970.
doi: 10.1056/NEJMc1311795.

Pazopanib versus sunitinib in renal cancer

Robert J Motzer, Lauren McCann, Keith Deen
Comment

Pazopanib versus sunitinib in renal cancer

Robert J Motzer et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
    Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, Boleti E, Fife K, Jin J, Jones R, Uemura H, De Giorgi U, Harmenberg U, Wang J, Sternberg CN, Deen K, McCann L, Hackshaw MD, Crescenzo R, Pandite LN, Choueiri TK. Motzer RJ, et al. N Engl J Med. 2013 Aug 22;369(8):722-31. doi: 10.1056/NEJMoa1303989. N Engl J Med. 2013. PMID: 23964934 Clinical Trial.
  • Pazopanib versus sunitinib in renal cancer.
    Ramaekers R, Tharnish M, Copur MS. Ramaekers R, et al. N Engl J Med. 2013 Nov 14;369(20):1968-9. doi: 10.1056/NEJMc1311795. N Engl J Med. 2013. PMID: 24224636 No abstract available.
  • Pazopanib versus sunitinib in renal cancer.
    Wittes J. Wittes J. N Engl J Med. 2013 Nov 14;369(20):1969. doi: 10.1056/NEJMc1311795. N Engl J Med. 2013. PMID: 24224637 No abstract available.
  • Pazopanib versus sunitinib in renal cancer.
    Casper J, Schumann-Binarsch S, Köhne CH. Casper J, et al. N Engl J Med. 2013 Nov 14;369(20):1969. doi: 10.1056/NEJMc1311795. N Engl J Med. 2013. PMID: 24224638 No abstract available.

LinkOut - more resources